M&T Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $339K | Sell |
1,792
-230
| -11% | -$40.2K | ﹤0.01% | 1314 |
|
|
2025
Q4 | $344K | Buy |
+2,022
| New | +$310K | ﹤0.01% | 1321 |
|
|
2025
Q3 | – | Sell |
-2,324
| Closed | -$247K | – | 1548 |
|
|
2025
Q2 | $247K | Sell |
2,324
-878
| -27% | -$95.4K | ﹤0.01% | 1354 |
|
|
2025
Q1 | $398K | Sell |
3,202
-633
| -17% | -$82.6K | ﹤0.01% | 1149 |
|
|
2024
Q4 | $473K | Buy |
3,835
+246
| +7% | +$29K | ﹤0.01% | 1197 |
|
|
2024
Q3 | $400K | Sell |
3,589
-743
| -17% | -$81.4K | ﹤0.01% | 1242 |
|
|
2024
Q2 | $462K | Buy |
4,332
+951
| +28% | +$105K | ﹤0.01% | 1145 |
|
|
2024
Q1 | $407K | Sell |
3,381
-948
| -22% | -$116K | ﹤0.01% | 1213 |
|
|
2023
Q4 | $533K | Sell |
4,329
-402
| -8% | -$50.2K | ﹤0.01% | 1104 |
|
|
2023
Q3 | $613K | Sell |
4,731
-1,587
| -25% | -$211K | ﹤0.01% | 1001 |
|
|
2023
Q2 | $783K | Sell |
6,318
-3,455
| -35% | -$465K | ﹤0.01% | 955 |
|
|
2023
Q1 | $1.43M | Buy |
9,773
+1,655
| +20% | +$245K | 0.01% | 740 |
|
|
2022
Q4 | $1.29M | Buy |
8,118
+423
| +5% | +$62K | 0.01% | 764 |
|
|
2022
Q3 | $1.03M | Sell |
7,695
-872
| -10% | -$133K | ﹤0.01% | 825 |
|
|
2022
Q2 | $506K | Buy |
8,567
+5,244
| +158% | +$807K | ﹤0.01% | 1002 |
|
|
2022
Q1 | $518K | Buy |
3,323
+401
| +14% | +$58.2K | ﹤0.01% | 970 |
|
|
2021
Q4 | $372K | Sell |
2,922
-53
| -2% | -$6.96K | ﹤0.01% | 1154 |
|
|
2021
Q3 | $387K | Sell |
2,975
-15
| -0.5% | -$2.27K | ﹤0.01% | 1125 |
|
|
2021
Q2 | $530K | Sell |
2,990
-5
| -0.2% | -$866 | ﹤0.01% | 1006 |
|
|
2021
Q1 | $492K | Sell |
2,995
-286
| -9% | -$47.1K | ﹤0.01% | 1010 |
|
|
2020
Q4 | $542K | Sell |
3,281
-7,162
| -69% | -$1.07M | ﹤0.01% | 1008 |
|
|
2020
Q3 | $1.49M | Sell |
10,443
-88
| -0.8% | -$10.9K | 0.01% | 596 |
|
|
2020
Q2 | $1.16M | Buy |
10,531
+880
| +9% | +$97.3K | 0.01% | 643 |
|
|
2020
Q1 | $962K | Sell |
9,651
-902
| -9% | -$117K | 0.01% | 695 |
|
|
2019
Q4 | $1.58M | Sell |
10,553
-762
| -7% | -$104K | 0.01% | 497 |
|
|
2019
Q3 | $1.45M | Buy |
11,315
+1,860
| +20% | +$249K | 0.01% | 608 |
|
|
2019
Q2 | $1.35M | Sell |
9,455
-1,185
| -11% | -$159K | 0.01% | 641 |
|
|
2019
Q1 | $1.52M | Buy |
10,640
+6,015
| +130% | +$785K | 0.01% | 595 |
|
|
2018
Q4 | $572K | Buy |
4,625
+295
| +7% | +$43.8K | ﹤0.01% | 866 |
|
|
2018
Q3 | $729K | Sell |
4,330
-146
| -3% | -$25.1K | ﹤0.01% | 868 |
|
|
2018
Q2 | $771K | Buy |
+4,476
| New | +$732K | ﹤0.01% | 856 |
|
|
2017
Q2 | – | Sell |
-1,518
| Closed | -$221K | – | 1652 |
|
|
2017
Q1 | $221K | Buy |
+1,518
| New | +$198K | ﹤0.01% | 1419 |
|
|
2016
Q4 | – | Sell |
-2,697
| Closed | -$327K | – | 1733 |
|
|
2016
Q3 | $327K | Buy |
2,697
+903
| +50% | +$122K | ﹤0.01% | 1239 |
|
|
2016
Q2 | $254K | Sell |
1,794
-2,513
| -58% | -$370K | ﹤0.01% | 1341 |
|
|
2016
Q1 | $562K | Sell |
4,307
-10,156
| -70% | -$1.26M | ﹤0.01% | 990 |
|
|
2015
Q4 | $2.04M | Sell |
14,463
-3,052
| -17% | -$423K | 0.01% | 555 |
|
|
2015
Q3 | $2.33M | Sell |
17,515
-4,056
| -19% | -$698K | 0.02% | 515 |
|
|
2015
Q2 | $3.8M | Sell |
21,571
-1,181
| -5% | -$212K | 0.02% | 418 |
|
|
2015
Q1 | $3.93M | Buy |
22,752
+567
| +3% | +$97.3K | 0.02% | 432 |
|
|
2014
Q4 | $3.63M | Buy |
22,185
+2,020
| +10% | +$335K | 0.02% | 460 |
|
|
2014
Q3 | $3.24M | Buy |
+20,165
| New | +$3.1M | 0.02% | 496 |
|
|
2014
Q2 | – | Sell |
-13
| Closed | -$2K | – | 1116 |
|
|
2014
Q1 | $2K | Buy |
+13
| New | +$1.96K | ﹤0.01% | 1124 |
|
Other funds holding JAZZ
VPM
VCM
EC
M&T Bank's JAZZ Position: Q1 2026 in Review
M&T Bank reduced its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q1 2026, selling an estimated $40.2K and leaving 1,792 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1314.
M&T Bank first reported a position in JAZZ in Q1 2014 and has held it in 42 quarters since. The position peaked at $3.93M in Q1 2015. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- M&T Bank held 1,792 shares of Jazz Pharmaceuticals worth $339K as of Q1 2026.
- M&T Bank sold 230 Jazz Pharmaceuticals shares in Q1 2026, an estimated $40.2K.
- Jazz Pharmaceuticals made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1314 holding.
- M&T Bank first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 42 quarters since.
- M&T Bank's Jazz Pharmaceuticals position peaked at $3.93M in Q1 2015.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.